AMLX logo

Amylyx Pharmaceuticals, Inc. (AMLX) Non current assets

Annual non current assets:

$4.20M-$48.59M(-92.04%)
December 31, 2024

Summary

  • As of today (September 18, 2025), AMLX annual long term assets is $4.20 million, with the most recent change of -$48.59 million (-92.04%) on December 31, 2024.
  • During the last 3 years, AMLX annual non current assets has risen by +$3.54 million (+533.79%).
  • AMLX annual non current assets is now -92.04% below its all-time high of $52.79 million, reached on December 31, 2023.

Performance

AMLX Non current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXbalance sheet metrics

quarterly non current assets:

$7.71M+$4.18M(+118.23%)
June 1, 2025

Summary

  • As of today (September 18, 2025), AMLX quarterly long term assets is $7.71 million, with the most recent change of +$4.18 million (+118.23%) on June 1, 2025.
  • Over the past year, AMLX quarterly non current assets has increased by +$2.27 million (+41.69%).
  • AMLX quarterly non current assets is now -85.40% below its all-time high of $52.79 million, reached on December 31, 2023.

Performance

AMLX quarterly non current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXbalance sheet metrics

Non current assets Formula

Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets

AMLX Non current assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-92.0%+41.7%
3 y3 years+533.8%-15.3%
5 y5 years+10000.0%+1557.6%

AMLX Non current assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-92.0%+533.8%-85.4%+118.2%
5 y5-year-92.0%>+9999.0%-85.4%+1557.6%
alltimeall time-92.0%>+9999.0%-85.4%+1557.6%

AMLX Non current assets History

DateAnnualQuarterly
Jun 2025
-
$7.71M(+118.2%)
Mar 2025
-
$3.53M(-15.9%)
Dec 2024
$189.43M(-59.2%)
$4.20M(-22.9%)
Sep 2024
-
$5.45M(+0.2%)
Jun 2024
-
$5.44M(-21.4%)
Mar 2024
-
$6.92M(-86.9%)
Dec 2023
$464.67M
$52.79M(+62.6%)
Sep 2023
-
$32.47M(+24.0%)
DateAnnualQuarterly
Jun 2023
-
$26.19M(+38.6%)
Mar 2023
-
$18.91M(+102.8%)
Dec 2022
$382.13M(+264.1%)
$9.32M(+0.8%)
Sep 2022
-
$9.24M(+1.6%)
Jun 2022
-
$9.10M(+1.7%)
Mar 2022
-
$8.95M(+1249.9%)
Dec 2021
$104.95M(+669.5%)
$663.00K(+42.6%)
Dec 2020
$13.64M(+326.0%)
$465.00K
Dec 2019
$3.20M
-

FAQ

  • What is Amylyx Pharmaceuticals, Inc. annual long term assets?
  • What is the all time high annual non current assets for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. annual non current assets year-on-year change?
  • What is Amylyx Pharmaceuticals, Inc. quarterly long term assets?
  • What is the all time high quarterly non current assets for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. quarterly non current assets year-on-year change?

What is Amylyx Pharmaceuticals, Inc. annual long term assets?

The current annual non current assets of AMLX is $4.20M

What is the all time high annual non current assets for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high annual long term assets is $52.79M

What is Amylyx Pharmaceuticals, Inc. annual non current assets year-on-year change?

Over the past year, AMLX annual long term assets has changed by -$48.59M (-92.04%)

What is Amylyx Pharmaceuticals, Inc. quarterly long term assets?

The current quarterly non current assets of AMLX is $7.71M

What is the all time high quarterly non current assets for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high quarterly long term assets is $52.79M

What is Amylyx Pharmaceuticals, Inc. quarterly non current assets year-on-year change?

Over the past year, AMLX quarterly long term assets has changed by +$2.27M (+41.69%)
On this page